0 results for 'U.S. Food and Drug Administration'
Looming Clash Over Abortion Pills Shows Overturning 'Roe v. Wade' Settled Nothing
The irony of the lawsuit is that the overturning of Roe v. Wade was justified in many quarters by returning the decision to the states, but that rationale is eviscerated if states can come after citizens of other states who are committing acts that are legal in their states.First-of-Its-Kind Parkinson’s Patch at Center of Fight Over FDA Approval of Generic Version
New Jersey-based pharmaceutical company UCB has sued to protect its patents for a Parkinson’s drug after an India-based company attempted to file an FDA application to create a generic version.Cannabis Took a Hit on Red Wednesday, but Hope Is On the Way
Reflecting multiple states rejection of marijuana legalization efforts and ushering in an administration seemingly hostile to cannabis, Red Wednesday revealed how uncertain regulatory policy, coupled with Herculean operational challenges, stripped the bloom off of the rose and unveiled the volatility of cannabis’ valuation.Five Noteworthy Litigation Trends of 2024—and What to Watch in 2025
With the potential to redefine key areas of the law, here are the five most interesting litigation hotspots spotted by Law.com Radar in 2024.Pharma Giants File Patent Infringement Suit Against India-Based Drugmaker Over IBS Medication
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.View more book results for the query "U.S. Food and Drug Administration"
Here We Go Again: The Fosamax Preemption Saga Continues
Unless the Third Circuit’s decision is reversed, this decision revives hundreds of cases, many of which have been dormant since at least 2017.Litigation Surge: Drugmakers Launch Flood of Suits to Halt Generics
At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits per month in the period from December 2023 to November 2024. The multitude of suits include many that stem from generic drugmakers' plans to sell lower-priced versions of recognized pharmaceutical products.Baker Botts' Biopharma Client Sues Former In-House Attorney, Others Alleging Extortion Scheme
"They look forward to vigorously litigating these matters in a public forum in the coming weeks and months," said Evan Gotlob, a partner at Lucosky Brookman in New Jersey, denying allegations of wrongdoing against the defendants.FDA Defends Rejection of Vape-Flavor Applications Before Sympathetic Supreme Court
"Common sense tells you that a flavor like 'Mother's Milk and Cookies' is going to be disproportionately attractive to children," Deputy U.S. Solicitor General Curtis Gannon told the justices.At FDA, Flavored Vape Products Go Up In Smoke
The Supreme Court will consider the U.S. Food and Drug Administration's tough stance on allowing new flavored vape products on the market.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Why Embracing Change Is Essential for Your Legal Department
Brought to you by DiliTrust
Download Now
International Export and Trade Assistance State Law Survey
Brought to you by LexisNexis®
Download Now
How This Personal Injury Firm Reduced Client Intake Time by 80%
Brought to you by PracticePanther
Download Now
The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation
Brought to you by Erase.com
Download Now